Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids

European Journal of Pharmacology

Volumn 611, Issue 1-3, 2009, Pages 1-7

  Caporale, Andrea ^a,b   Biondi, Barbara ^b   Schievano, Elisabetta ^a,b   Wittelsberger, Angela ^c   Mammi, Stefano ^a,b   Peggion, Evaristo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone resorption; CD; Hypercalcemia; NMR; PTHrP (PTH related protein); SPPS (synthesis on solid phase)

Indexed keywords

CARBON; CARBONYL DERIVATIVE; DEXTRO AMINO ACID; DEXTRO HOMOARGININE; DEXTRO HOMOARGININE ALPHA AMINOISOBUTYRIC ACID VALYL ALPHA AMINOISOBUTYRIC ACID GLUTAMYLISOLEUCYLGLUTAMINYLLEUCYLNORLEUCYLHISTIDYLGLUTAMINYLHOMOARGINAMIDE; DEXTRO VALINE; HOMOARGININE; N (9 FLUORENYL)METHYLOXYCARBONYL DERIVATIVE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE[1-11] DERIVATIVE; UNCLASSIFIED DRUG; VALINE;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG STRUCTURE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REACTION ANALYSIS; SOLID PHASE SYNTHESIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; CELL LINE; CIRCULAR DICHROISM; HUMANS; MOLECULAR SEQUENCE DATA; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67349122041     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.040     Document Type: Article

References (48)

1. Barazza A., Wittelsberger A., Fiori N., Schievano E., Mammi S., Toniolo C., Alexander J.M., Rosenblatt M., Peggion E., and Chorev M. Bioactive N-terminal undecapeptides derived from parathyroid hormone: the role of alpha-helicity. J. Pept. Res. 65 (2005) 23-35
2. Bax A., and Davis D.G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63 (1985) 207-213
3. Bax A., and Davis D.G. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65 (1985) 355-360
4. Borek F., Stupp Y., Fuchs S., and Sela M. Relation between optical configuration and immunogenicity of synthetic polypeptides. Biochem. J. 96 (1965) 577-582
5. Buck M. Trifluoroethanol and colleagues: Cosolvents come of age. Q. Rev. Biophys. 31 (1998) 297-355
6. Cali J.J., Niles A., Valley M.P., O'Brien M.A., Riss T.L., and Shultz J. Bioluminescent assays for ADMET. Expert Opin. Drug Metab. Toxicol. 4 (2008) 103-120
7. Caporale, A., Fiori, N., Schievano, E., Wittelsberger, A., Mammi, S., Chorev, M., Peggion, E., in press. Structure-Function Relationship Study of Parathyroid Hormone(1-11) Analogues Containing d-AA. In: Escher, E., Lubell, W.D., Del Valle, S. (Eds.) Peptides for Youth, American Peptide Society, Montreal, CANADA.
8. Carpino L.A. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. J. Am. Chem. Soc. 115 (1993) 4397-4398
9. Carpino L.A., and El-Faham A. Effect of tertiary bases on O-benzotriazolyluronium salt-induced peptide segment coupling. J. Org. Chem. 59 (1994) 695-698
10. Carpino L.A., El-Faham A., Minor C.A., and Albericio F. Advantageous applications of azabenzotriazole (triazolopyridine)-based coupling reagents to solid-phase peptide synthesis. J. Soc. Chem. Commun. (1994) 201-203
11. Carpino L.A., El-Faham A., and Albericio F. Efficiency in peptide coupling: 1-hydroxy-7-azabenzotriazole vs 3,4-dihydro-3-hydroxy-4-oxo-1,2,3-benzotriazine. J. Org. Chem. 60 (1995) 3561-3564
12. Chorev M., and Rosenblatt M. The Parathyroids (1994), Raven Press, NY 139-156
13. α-tetrasubstituted alpha-amino acid residues and sequence dependence. Biopolymers 64 (2002) 236-245
14. Cushman M., Jurayj J., and Moyer J.D. Synthesis, biological testing, and stereochemical assignment of an end group modified retro-inverso bombesin C-terminal nonapeptide. J. Org. Chem. 55 (1990) 3186-3194 (and references therein)
15. Drake B., Patek M., and Lebl M. A convenient preparation of monosubstituted N,N′-di(Boc)-protected guanidines. Synthesis 6 (1994) 579-582
16. Fan F., and Wood K.V. Bioluminescent assay for high-throughput screening. Assay Drug Dev. Technol. 5 (2007) 127-136
17. Feichtinger K., Zapf C., Sings H., and Goodman M. Diprotected triflylguanidines: a new class of guanidinylation reagents. J. Org. Chem. 63 (1998) 3804-3805
18. Frelinger A.L., and Zull J.E. Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18. J. Biol. Chem. 259 (1984) 5507-5513
19. Gante J. Peptidomimetics - tailored enzyme inhibitors. Angew. Chem. 33 (1994) 1699-1720
20. Gardella T.J., and Jüppner H. Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol. Metab. 5 (2001) 210-217
21. Gill T.J., Hanna J.G., and Doty P. Role of optical isomers in determining the antigenicity of synthetic polypeptides. Nature 197 (1963) 746-747
22. Goodman M., and Chorev M. On the concept of linear modified retro-peptide structures. Acc. Chem. Res. 12 (1979) 1-7
23. Goodman M., and Listowsky I. Conformational aspects of synthetic polypeptides. VI. Hypochromic spectral studies of oligo-α-methyl-l-glutamate peptides. J. Am. Chem. Soc. 84 (1962) 3770-3771
24. Griesinger C., Otting G., Wüthrich K., and Ernst R.R. Clean TOCSY for proton spin system identification in macromolecules. J. Am. Chem. Soc. 110 (1988) 7870-7872
25. Hirschmann R. Medicinal chemistry in the golden age of biology: lessons from steroid and peptide research. Angew. Chem. 30 (1991) 1278-1301
26. Jüppner H., Abou-Samra A.-B., Freeman M., Kong X.-F., Schipani E., Richards J., Kolakowski Jr. L.F., Hock J., Potts Jr. J.T., Kronenberg H.M., and Segre G.V. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254 (1991) 1024-1026
27. Kessler H., Diefenbach B., Finsinger F., Geyer A., Gurrath M., Goodman S.L., Hölzemann G., Haubner R., Jonczyk A., Müller G., Graf von Roedern E., and Wermuth J. Design of superactive and selective integrin receptor antagonists containing the RGD sequence. Lett. Pept. Sci. 2 (1995) 155-160
28. Knorr R., Trzeciak A., Bannwarth W., and Gillessen D. New coupling reagents in peptide chemistry. Tetrahedron Lett. 30 (1989) 1927-1930
29. Kronenberg H., Abou-Samra A., Bringhurst F., Gardella T.J., Jüppner H., and Segre G. In: Thakker R. (Ed). Genetics of Endocrine and Metabolic Disorders (1997), Chapman & Hall, London 389-420
30. Martin L., Ivancich A., Vita C., Formaggio F., and Toniolo C. Solid-phase synthesis of peptides containing the spin label 2,2,6,6-tetramethylpiridine-1-oxyl-4-amino-4carboxyl acid (TOAC). J. Pept. Res. 58 (2001) 424-432
31. Monticelli L., Mammi S., and Mierke D.F. Molecular characterization of a ligand-tethered parathyroid hormone receptor. Biophys. Chem. 95 (2002) 165-172
32. Pastore A., and Saudek V. The relationship between chemical shift and secondary structure in proteins. J. Magn. Reson. 90 (1990) 165-176
33. Pines M., Adams A.E., Stueckle S., Bessalle R., Rashti-Behar V., Chorev M., Rosenblatt M., and Suva L.J. Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: lack of interaction with a C-terminal human PTH peptide. Endocrinology 135 (1994) 1713-1716
34. Potts J.T., and Gardella T.J. Progress, paradox, and potential: parathyroid hormone research over five decades. Ann. N.Y. Acad. Sci. 1117 (2008) 196-208
35. Quintana F.J., Gerber D., Bloch I., Cohen I.R., and Shai Y. A structurally altered d, l-amino acid TCRα transmembrane peptide interacts with the TCRα and inhibits T-cell activation in vitro and in an animal model. Biochemistry 46 (2007) 2317-2325
36. Rance M., Sorensen O.W., Bodenhausen G., Wagner G., Ernst R.R., and Wüthrich K. Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117 (1983) 479-485
37. Rosenblatt M., Goltzmann D., Keutmann H.T., Tregear G.W., and Potts Jr. J.T. Chemical and biological properties of synthetic, sulfur-free analogues of parathyroid hormone. J. Biol. Chem. 251 (1976) 159-164
38. Schumacher T.N., Mayr L.M., Minor Jr. D.L., Milhollen M.A., Burgess M.W., and Kim P.S. Identification of d-peptide ligands through mirror-image phage display. Science 271 (1996) 1854-1857
39. Scian M., Marin M., Bellanda M., Tou L., Alexander J.M., Rosenblatt M., Chorev M., Peggion E., and Mammi S. Backbone dynamics of human parathyroid hormone (1-34): flexibility of the central region under different environmental conditions. Biopolymers 84 (2006) 147-160
40. Shimizu M., Carter P.H., and Gardella T.J. Autoactivation of type-1 parathyroid hormone receptors containing a tethered ligand. J. Biol. Chem. 275 (2000) 19456-19460
41. Shimizu M., Potts Jr. J.T., and Gardella T.J. Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J. Biol. Chem. 275 (2000) 21836-21843
42. Shimizu M., Carter P.H., Khatri A., Potts Jr. J.T., and Gardella T.J. Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions. Endocrinology 142 (2001) 3068-3074
43. Shimizu M., Guo J., and Gardella T.J. Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J. Biol. Chem. 276 (2001) 49003-49012
44. Shimizu N., Shimizu M., Tsang J.C., Petroni B.D., Khatri A., Potts J.T., and Gardella T.J. Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor. Biochemistry 41 (2002) 13224-13233
45. Shimizu N., Petroni B.D., Khatri A., and Gardella T.J. Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues. Biochemistry 42 (2003) 2282-2290
46. Shimizu M., Dean T., Khatri A., and Gardella T.J. Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3. J. Bone Miner. Res. 19 (2004) 2078-2086
47. Tsomaia N., Pellegrini M., Hyde K., Gardella T.J., and Mierke D.F. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues. Biochemistry 43 (2004) 690-699
48. Yang J.T., Wu C.S., and Martinez H.M. Calculation of protein conformation from circular dichroism. Methods Enzymol. 130 (1986) 208-269